NEVVI Medicare utilization intelligence

← back

RATLIFF, THOMASMD NPI 1639170665 Clinician

Hematology-Oncology · GERMANTOWN, TN

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS — medical school, self-reported to CMS
In practice about 39 years since medical school (class of 1987, self-reported to CMS)
Location GERMANTOWN, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 86 codes billed · 66,444 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
THE WEST CLINIC P.C.
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2017-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0897 Injection, denosumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J9267 Injection, paclitaxel, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80048 Blood test, basic group of blood chemicals (calcium, total)
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80076 Liver function blood test panel
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
36415 Insertion of needle into vein for collection of blood sample
88185 Flow cytometry technique for dna or cell analysis, each additional marker
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J0461 Injection, atropine sulfate, 0.01 mg
J0640 Injection, leucovorin calcium, per 50 mg
82306 Vitamin d-3 level
82784 Gammaglobulin (immune system protein) measurement
82728 Ferritin (blood protein) level
J2469 Injection, palonosetron hcl, 25 mcg
83540 Iron level
83550 Iron binding capacity
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J9190 Injection, fluorouracil, 500 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83883 Nephelometry, test method using light
84443 Blood test, thyroid stimulating hormone (tsh)
J3480 Injection, potassium chloride, per 2 meq
96413 Administration of chemotherapy into vein, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3475 Injection, magnesium sulfate, per 500 mg
96372 Injection of drug or substance under skin or into muscle
82565 Blood creatinine level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
83735 Magnesium level
85610 Blood test, clotting time
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96375 Injection of additional new drug or substance into vein
84153 Psa (prostate specific antigen) measurement, total
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82746 Folic acid level, serum
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J1200 Injection, diphenhydramine hcl, up to 50 mg
96415 Administration of chemotherapy into vein, each additional hour
83615 Lactate dehydrogenase (enzyme) level
J3490 Unclassified drugs
88184 Flow cytometry technique for dna or cell analysis, first marker
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
85045 Red blood count, automated test
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96417 Administration of additional new drug or substance into vein, 1 hour or less
97140 Therapy procedure using manual technique, each 15 minutes
84439 Thyroxine (thyroid chemical), free
86431 Rheumatoid factor level
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
80061 Blood test, lipids (cholesterol and triglycerides)
84550 Uric acid level, blood
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
81003 Automated urinalysis test
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
82947 Blood glucose (sugar) level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96411 Administration of additional new drug or substance into vein using push technique
82232 Beta-2 microglobulin (protein) level
84100 Phosphate level
97535 Training for self-care or home management, each 15 minutes
96361 Infusion into a vein for hydration, each additional hour
38222 Biopsy and aspiration of bone marrow sample for diagnosis
G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth
96360 Infusion into a vein for hydration, 31-60 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.